Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Tango Therapeutics (TNGX) Assets Average (2020 - 2025)

Historic Assets Average for Tango Therapeutics (TNGX) over the last 6 years, with Q3 2025 value amounting to $224.0 million.

  • Tango Therapeutics' Assets Average fell 3895.01% to $224.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $224.0 million, marking a year-over-year decrease of 3895.01%. This contributed to the annual value of $359.5 million for FY2024, which is 1429.95% down from last year.
  • Latest data reveals that Tango Therapeutics reported Assets Average of $224.0 million as of Q3 2025, which was down 3895.01% from $256.1 million recorded in Q2 2025.
  • Tango Therapeutics' Assets Average's 5-year high stood at $515.1 million during Q4 2021, with a 5-year trough of $167.9 million in Q2 2021.
  • For the 5-year period, Tango Therapeutics' Assets Average averaged around $367.3 million, with its median value being $393.8 million (2024).
  • In the last 5 years, Tango Therapeutics' Assets Average soared by 17427.96% in 2021 and then tumbled by 3895.01% in 2025.
  • Tango Therapeutics' Assets Average (Quarter) stood at $515.1 million in 2021, then decreased by 12.59% to $450.3 million in 2022, then decreased by 7.76% to $415.4 million in 2023, then dropped by 19.48% to $334.5 million in 2024, then tumbled by 33.02% to $224.0 million in 2025.
  • Its last three reported values are $224.0 million in Q3 2025, $256.1 million for Q2 2025, and $295.4 million during Q1 2025.